VARUNÉ Bio

Explore VARUNÉ Bio.

Polar Seas Luminous Coasts
Research & development enquiries

What are you curious about?

Start with

Film credits

Biology, with somewhere to go.

Biological materials for the difficult part of development: a better-performing film, a useful light signal and the evidence that makes a new approach worth choosing.

VARUNÉ Bio | Company and research direction.

A function worth developing.

An unusual biological source becomes valuable when it changes what a developer can do.

VARUNÉ Bio is being built at the meeting point between biological function and materials development. We want to turn a promising research lead into a preparation a scientist can identify, a comparison a formulator can trust and a proposition a prospective buyer can evaluate. The destination is useful material knowledge, not a collection of striking origin stories.

For a beauty or ingredient R&D team, the relevant opportunity is a contribution to the formula it needs to develop. For a research-tool or materials developer, it is a function that justifies the operating requirements. For an investor, it is the evidence that could make the next development asset more credible.

Polar biology. A formulation opportunity.

Our first application focus is the layer a skin formulation leaves behind.

The polar-materials programme asks whether an accountable biological polymer can contribute useful water-related behaviour in a deposited film. Its development brief connects the material, the mixture and the applied layer. A formulator should be able to ask which preparation is under consideration, what it contributes and how that contribution compares with the current alternative.

Published polar-polymer work supplies scientific leads. Casillo and colleagues connected chemical and NMR characterisation of a secreted Colwellia polysaccharide with a cryoprotection investigation. That structure-to-function approach is relevant research context; the ice-related result remains distinct from our intended ambient film question (Casillo et al., 2017).

(Casillo, A. et al, 2017)

Light, given a useful role.

The second programme asks how a reaction could become a material function.

Biochemical light opens a different development conversation: can an active system deliver an appropriate signal where a user needs it? Our intended starting setting is an inert surface or research tool. The brief needs to connect active-component retention, access to reaction inputs, output, duration and handling. The value would come from the use those relationships make possible.

The NanoLuc work of Hall and colleagues shows the importance of developing an enzyme alongside its substrate in a configured reporter system (Hall et al., 2012). A material proposition has further questions to answer. We are giving those questions their own programme rather than borrowing the reporter’s performance as a product claim.

(Hall, M.P. et al, 2012)

From a biological function to a material brief.

The application gives the science its next question.

Film credits

Formulation is where the idea meets the brief.

The material has to work with the rest of the system.

A development discussion becomes useful when it names the constraints that cannot be traded away. A candidate might need to preserve application behaviour, tolerate a process or produce an acceptable layer while contributing something the existing approach struggles to deliver. Those demands determine the comparison and the expertise needed to interpret it.

Our formulation direction is to examine identity, composition, interfaces and use together. The practical output could be a sharper material specification, an application comparison or a better explanation of why a promising response appears. That knowledge can make the next research or commercial discussion more substantial.

Building an asset around the evidence.

A milestone should leave the company with something a developer can investigate.

We are shaping the company around outputs that could carry into further work: characterisation records, preparation knowledge, interpretable comparisons and formulation approaches. Their value depends on reproducibility, permitted use and relevance to an application. A compelling observation becomes a stronger asset when another team can understand how it was obtained and why it matters.

This gives investment a scientific purpose. The next commitment should resolve a consequential uncertainty: whether the material can be defined, whether the contribution survives a useful comparison or whether the operating burden fits a prospective use. Each answer changes what is worth developing next.

The right people make the question sharper.

Complementary expertise belongs around a defined package.

Our directions call for polymer and material analysis, formulation science, enzyme chemistry, optical measurement and evidence interpretation in different combinations. A prospective partner can contribute an important method, a more demanding benchmark or a better account of the problem. The research question should make the contribution clear.

A commercial or scientific discussion can establish the proposed output, access, responsibility and resources. If protected information becomes necessary, the purpose and confidentiality arrangements can be addressed before it is shared. The public programme gives enough direction to begin without publishing an unpublished method or a partner’s private material.

A public record worth exploring.

The site connects the programme story with the sources behind it.

Programme pages explain the proposed comparisons. Scientific views let a reader investigate reference molecules, material states and the meaning of a measurement. The Journal develops the company’s reasoning. Together they should help a visitor move from curiosity to a more exact development question.

The analytical-resource direction adds another useful layer: a traceable connection between a source, its reported observation, our interpretation and a proposed hypothesis. FAIR principles provide a reference for provenance and reuse (Wilkinson et al., 2016). The aim is an experience a scientist can question and an investor can use to understand the next milestone.

(Wilkinson, M.D. et al, 2016)

The difference under investigation.

Turn the scientific question into a comparison with a useful output.

Film credits

The part your current approach cannot solve.

A serious introduction gives the opportunity a starting point.

For a formulation team, bring the performance requirement and the compromise in the current system. For an ingredient business, bring the preparation and the application evidence it still needs. For a research partner, bring the capability that could resolve the uncertainty. For an investor, bring the question about the asset and the evidence needed for the next commitment.

Varun Sharma leads this company direction. VARUNÉ Bio is the trading name of VARUNÉ BIOSYSTEMS LTD, registered in England and Wales under number 16820832, with its registered office at 5 Brayford Square, London, E1 0SG.

Give the next development step a purpose.

A short, non-confidential introduction can outline the application, the current approach, and where scientific input could help. Scope and next steps would be agreed around the actual project.

Discuss the development question

Sources and reading notes.

External work is identified below. Access notes describe the material inspected for this page; company research questions and proposed work are not presented as findings from these sources.

Casillo, A. et al, 2017Casillo, A. et al. (2017) Structure-activity relationship of the exopolysaccharide from a psychrophilic bacterium: A strategy for cryoprotection. Carbohydrate Polymers, 156, pp. 364–371. doi:10.1016/j.carbpol.2016.09.037.

External Colwellia research connects chemical/NMR structure characterisation of a secreted EPS with a cryoprotection investigation.

Scope and limitations: Cold-environment and ice-related reference; no demonstrated ambient skin-film benefit or selected Bio ingredient follows. No spectra or simulations reanalysed.

Author-institution accepted-manuscript abstract and PubMed bibliographic record inspected · Source checked 2026-10-14

Open original source
Hall, M.P. et al, 2012Hall, M.P. et al. (2012) Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate. ACS Chemical Biology, 7(11), pp. 1848–1857. doi:10.1021/cb3002478.

NanoLuc was developed by joint enzyme and substrate optimisation; reported glow behaviour is tied to configured reporter assays.

Scope and limitations: Abstract-level verification. Reported assay outputs do not establish an ambient visible material, product safety, freely available intellectual property or Bio findings.

PubMed abstract and bibliographic record inspected · Source checked 2026-10-14

Open original source
Wilkinson, M.D. et al, 2016Wilkinson, M.D. et al. (2016) The FAIR Guiding Principles for scientific data management and stewardship. Scientific Data, 3, 160018. doi:10.1038/sdata.2016.18.

Findable, Accessible, Interoperable and Reusable principles include persistent identifiers, provenance, licensing and possible authentication.

Scope and limitations: Guiding principles rather than certification or proof of an implemented Bio data service. FAIR does not mean unrestricted commercial reuse.

Publisher-indexed principles and discussion inspected · Source checked 2026-10-14

Open original source